nicotinamide mononucleotide has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, H; Ding, W; Liu, X; Luo, C; Yang, C; Zhang, W | 1 |
1 other study(ies) available for nicotinamide mononucleotide and Chemical and Drug Induced Liver Injury, Chronic
| Article | Year |
|---|---|
Nicotinamide Mononucleotide Administration Restores Redox Homeostasis via the Sirt3-Nrf2 Axis and Protects Aged Mice from Oxidative Stress-Induced Liver Injury.
Topics: Animals; Chemical and Drug Induced Liver Injury, Chronic; Homeostasis; Mice; NF-E2-Related Factor 2; Nicotinamide Mononucleotide; Oxidation-Reduction; Oxidative Stress; Sirtuin 3 | 2022 |